Who owns Harmony Biosciences Holdings, Inc. (HRMY)? Elite investor 13F holders
5 tracked elite investors reported holding Harmony Biosciences Holdings, Inc as of 2026-06-30, including Renaissance Technologies LLC, Bridgewater Associates, D.E. Shaw, Gotham Asset Management, GMO. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also develops Pitolisant that…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | HARMONY BIOSCIENCES HLDGS IN | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 43523458.00 USD | 1195371.000000 | Shares | add | Original filing |
| Bridgewater Associates | HARMONY BIOSCIENCES HLDGS IN | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 9050616.00 USD | 248575.000000 | Shares | reduce | Original filing |
| D.E. Shaw | HARMONY BIOSCIENCES HLDGS IN | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1925324.00 USD | 52879.000000 | Shares | reduce | Original filing |
| Gotham Asset Management | HARMONY BIOSCIENCES HLDGS IN | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1305881.00 USD | 35866.000000 | Shares | reduce | Original filing |
| Tudor Investment | HARMONY BIOSCIENCES HLDGS IN | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| GMO | HARMONY BIOSCIENCES HLDGS IN | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 396541.00 USD | 10891.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.